|
|
|
| home > white papers > Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles - NanoSight |
|
|
 WHITE PAPERS |
|
NanoSight
|
|
Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles
|
|
The study of exosomes and other cell-derived microvesicles is
an area of rapidly growing importance and the subject of intense interest and
research. The previous lack of suitable methods for their detection, analysis,
enumeration and phenotyping is proving to be a significant limitation in these
studies. This mini-review shows the degree to which the technique of
Nanoparticle Tracking Analysis (NTA) is helping to address these problems.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
BioIVT Acquires Biological Specialty Corporation, Adds Donor Centers and Increases Its Immune Cell Capacity
BioIVT, a leading provider of research models and services for drug and
diagnostic development, today announced that it has acquired Biological
Specialty Corporation (BSC), a supplier of human blood products and
components to the life sciences research community for more than 37
years. BSC is headquartered in Colmar, PA, with two additional
FDA-registered donor centers in Allentown, PA and Reading, PA.
More info >> |
|
 |
White Papers |
 |
|
Choosing the Right CMO for HPAPI Manufacturing
AMRI
Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >> |
|
 |
Industry Events |
 |
14th Annual Biomarkers Congress
21-22 February 2019, Manchester Central Convention Complex, UK
Oxford Global is proud to present for the 14th year our
flagship Biomarkers Congress, taking place 21 – 22 February
2019 in Manchester, UK. An updated programme ensures you will benefit
from talks on the latest strategies and technologies impacting growth in
the biomarker industry.
More info >> |
|
|
|
